TdT Antibody, anti-human/mouse, REAfinity™
Synonyms: DNTT
RECOMBINANT EXTENDED VALIDATION
Clone:
REA1200 | 19-3
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:

Related products for TdT Antibody, anti-human/mouse, REAfinity™

Intracellular flow cytometry applications
APC
FITC
PE
PE-Vio 615
Vio B515
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-122-833
Description:
Thymocytes of C57/BL6 mice were fixed and permeabilized using the FoxP3 Staining Buffer Set. Cells were then stained with Anti-TdT antibodies or with the corresponding REA Control (I) antibodies (left images) as well as with CD8a antibodies. Cells were analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application imageView details view details

Application imageView details view details
Intracellular flow cytometry applications
Vio B515
Description:
Thymocytes of C57/BL6 mice were fixed and permeabilized using the FoxP3 Staining Buffer Set. Cells were then stained with Anti-TdT antibodies or with the corresponding REA Control (I) antibodies (left images) as well as with CD8a antibodies. Cells were analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.
Extended validation for TdT Antibody, anti-human/mouse, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA1200
19-3
high
3H2
low

Cells were incubated with an excess of purified unconjugated TdT (REA1200) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Specifications for TdT Antibody, anti-human/mouse, REAfinity™
Overview

Clone REA1200 recognizes terminal deoxynucleotidyl transferase (TdT), a template independent, 60 kDa DNA polymerase. TdT catalyzes addition of deoxynucleotides to the 3'-OH terminus of oligonucleotide primer segments. Expression of TdT is found in immature lymphocytes during early differentiation where it is involved in generating antigen receptor diversity by mediating Ig gene rearrangement.

Additional information: Clone REA1200 displays negligible binding to Fc receptors.

Alternative names

DNTT

Detailed product information

Technical specifications

Clone
REA1200
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human, mouse
Antigen
TdT
Molecular mass of antigen [kDa]
59
Distribution of antigen
lymphocytes
Entrez Gene ID
RRID
AB_2905442, AB_2801948, AB_2801950, AB_2801949, AB_2801952, AB_2801953, AB_2801954, AB_2801951

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for TdT Antibody, anti-human/mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for TdT Antibody, anti-human/mouse, REAfinity™
Publications
  1. Fowler, J. D. and Suo, Z. (2006) Biochemical, structural, and physiological characterization of terminal deoxynucleotidyl transferase. Chem. Rev. 106: 2092-2110

You have previously chosen International as your location.
What do you want to do?